IA
CBPO

Icon Advisers’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Icon Advisers’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-15,500
Closed -$1.75M – 443
2017
Q2 		$1.75M Hold
15,500
– – 0.12% 211
2017
Q1 		$1.55M Hold
15,500
– – 0.11% 228
2016
Q4 		$1.67M Hold
15,500
– – 0.11% 225
2016
Q3 		$1.93M Buy
+15,500
New +$1.83M 0.13% 214

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Icon Advisers's CBPO Position: Q3 2017 in Review

Icon Advisers sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 15,500 shares — an estimated $1.75M sold.

Icon Advisers first reported a position in CBPO in Q3 2016 and held it in 4 quarters. The position peaked at $1.93M in Q3 2016. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

  • Icon Advisers reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
  • Icon Advisers sold 15,500 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $1.75M.
  • Icon Advisers first reported a position in China Biologic Products Holdings, Inc. in Q3 2016 and held it in 4 quarters.
  • Icon Advisers's China Biologic Products Holdings, Inc. position peaked at $1.93M in Q3 2016.
  • 94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Icon Advisers's 13F filing for Q3 2017, filed 8 Nov 2017.